YOLFTbeta
NuGen Medical Devices Inc

NuGen Medical Devices Inc

NGMD · V · Healthcare / Medical Devices

0.015CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.015
Open0.015
Day Range0.015 – 0.015
52-Week Range0.015 – 0.055
Volume0
Market Cap3.41M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta1.57
50-Day Avg0.0152
200-Day Avg0.0229

About

NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is based in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Lin Liang
  • Employees0
  • Headquarters18 King Street East, Toronto, ON, Canada, M5C 1C4, Canada
  • Websitehttps://www.nugenmd.com

Leadership

  • Mr. Lin LiangCEO & Executive Chairman
  • Mr. Nicky CantonExecutive VP & COO · b. 1984
  • Ms. Karen DunlapInterim Chief Customer Officer & Director · b. 1948
  • Mr. Ajay MishraCFO & Corporate Secretary
  • Ms. Elisha DillonHead of Global Sales & Strategic Partnerships

Financials

Income Statement

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---47.30K137.65K152.36K331.40K1.01M257.95K
Growth (%)----+191.04%+10.69%+117.52%+204.73%-74.46%
Cost of Revenue---12.91K45.42K53.19K166.56K487.94K125.60K
Gross Profit---34.38K92.22K99.17K164.84K521.94K132.35K
Gross Margin---72.70%67.00%65.09%49.74%51.68%51.31%
Operating Expense---2.65M7.76M4.89M8.21M5.68M4.35M
Operating Income----2.61M-7.67M-4.79M-8.04M-5.16M-4.22M
Operating Margin----5521.05%-5573.13%-3142.26%-2426.29%-510.70%-1636.21%
EBITDA----2.59M-5.09M-3.91M-7.40M-2.90M-4.02M
EBITDA Margin----5473.21%-3697.89%-2566.89%-2233.32%-287.63%-1560.01%
Net Income----3.67M-7.11M-5.58M-9.36M-5.23M-7.83M
Net Income Margin----7760.66%-5163.23%-3661.07%-2825.02%-517.47%-3034.00%
Interest Expense000672.19K1.22M1.01M1.24M1.67M3.06M
Interest Expense % of Total Revenue---1421.27%888.86%663.89%373.05%165.23%1185.93%

Balance Sheet

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets---14.56M8.84M6.85M6.95M12.89M4.29M
Total Liabilities---15.25M7.19M9.11M9.01M18.57M18.03M
Total Equity----692.25K1.66M-2.26M-2.06M-5.67M-13.74M
Cash---266.35K1.75M131.45K464.46K6.95M3.14M
Net Debt---7.22M4.18M7.11M7.39M10.86M14.24M

Cash Flow

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-463.66K-1.35M-1.81M-1.39M-4.10M-4.88M-6.71M-4.71M-3.57M
Investing Cash Flow-162.05K-122.50K-57.16K52.72K-----
Financing Cash Flow3.12M2.64M-126.01K1.62M5.58M4.85M7.10M11.21M60.50K
Capital Expenditure12.05K1.93K5.53K5.53K3.57K1.01K3.02K10.38K302.31K
Free Cash Flow----1.40M-4.10M-4.89M-6.72M-4.72M-3.87M
FCF to OCF---100.40%100.09%100.07%100.05%100.22%108.48%

Earnings

Report DateDec 1, 2026
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap3.41M
Enterprise Value21.33M
Trailing P/E0.00
Forward P/E0.00
Price / Sales22.90
Price / Book34.96
EPS-0.04
Book Value-0.075
Revenue (TTM)148.72K
Gross Profit (TTM)71.13K
EBITDA-4.05M
Profit Margin0.00%
Operating Margin-19940.55%
Return on Equity-1472.02%
Return on Assets-41.76%
Shares Outstanding227.04M
Shares Float221.60M
Beta1.57
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%